Re: Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase 1 clinical trial.
Schmid
Hans-Peter
HP
Department of Urology, Kantonsspital St Gallen, Switzerland.